Document Detail


Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media.
MedLine Citation:
PMID:  9869558     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This multicenter, noncomparative, nonrandomized study evaluated the clinical efficacy and safety of ceftriaxone for treating acute otitis media in children following clinical failure of oral antibiotic therapy. Middle-ear fluid samples were collected on day 0 and on day 3, 4, or 5 (day 3 to 5) and were used to test whether ceftriaxone therapy can eradicate Streptococcus pneumoniae isolates with increased resistance to penicillin (MIC >/= 1 mg/liter). At the first visit, on day 0, middle-ear fluid was sampled for bacteriological testing by tympanocentesis or otorrhea pus suction. Patients were administered 50 mg of ceftriaxone/kg of body weight/day, injected intramuscularly once daily, for 3 days. A second sample was collected by tympanocentesis if a pneumococcus isolate for which the MIC of penicillin was >/=1 mg/liter was detected in the day-0 sample and if the middle-ear effusion persisted on day 3 to 5. This second sample was tested for bacterial eradication. One hundred eighty-six children aged 5 months to 5 years, 10 months, with acute otitis media clinical failure were enrolled and treated in this trial. On day 10 to 12, 145 (83.8%) of the 173 patients evaluable for clinical efficacy were clinically cured. Of the 59 patients infected by pneumococci, 36 had isolates for which the MICs of penicillin were >/=1 mg/liter. Of those patients, on day 10 to 12, 32 (88.9%) were clinically cured. Middle-ear fluid samples collected by day 3 to 5 following the onset of treatment with ceftriaxone were sterile for 24 of the 27 (88.9%) patients who were infected as of day 0 by pneumococci for which the MICs of penicillin were >/=1 mg/liter and who were evaluable for bacteriological eradication. On day 10 to 12, 81.4% of S. pneumoniae-infected children and 87.5% of Haemophilus influenzae-infected children were clinically cured. No discontinuation of treatment due to adverse events, particularly due to local reactions at the injection site, were reported. Only 11 adverse events which had doubtful, probable, or possible links with the study treatment were recorded. Both the bacteriologically assessed eradication of pneumococci for which the MICs of penicillin were >/=1 mg/liter and the clinical cure rates demonstrate that ceftriaxone is of value in the management of acute otitis media unresponsive to previous oral antibiotic therapy.
Authors:
P Gehanno; L Nguyen; B Barry; M Derriennic; F Pichon; J M Goehrs; P Berche
Related Documents :
25191198 - Anesthetic management of a patient with multiple sclerosis undergoing cesarean section ...
24769408 - Supramalleolar osteotomy with bone marrow stimulation for varus ankle osteoarthritis: c...
25056988 - Autologous chondrocyte implantation of the ankle: 2- to 10-year results.
23998038 - A prospective, randomized, double-blind study of coblation versus dissection tonsillect...
11743558 - Simultaneous aortic replacement and renal artery revascularization: the influence of pr...
17445638 - How small can we go? percutaneous nephrolithotomy using 6f nephroureteral catheter.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  43     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-03-25     Completed Date:  1999-03-25     Revised Date:  2013-04-17    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  16-20     Citation Subset:  IM    
Affiliation:
Service ORL, Hôpital Bichat, 75018 Paris, France. pierre.gehanno@bch.ap-hop-paris.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ceftriaxone / adverse effects,  therapeutic use*
Cephalosporins / adverse effects,  therapeutic use*
Child, Preschool
Female
Humans
Infant
Male
Otitis Media / drug therapy*,  microbiology
Penicillin Resistance*
Streptococcus pneumoniae / drug effects*,  isolation & purification
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cephalosporins; 73384-59-5/Ceftriaxone
Comments/Corrections
Erratum In:
Antimicrob Agents Chemother 1999 Jun;43(6):1532

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelia...
Next Document:  Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CS...